FATP

By Targets:	FATP (3) ATP Synthase (1) Bacterial (4) Endogenous Metabolite (1) Estrogen Receptor/ERR (1) Histone Acetyltransferase (1) Small Interfering RNA (siRNA) (3) STAT (1)
By Research Areas:	Cancer (1) Cardiovascular Disease (1) Infection (4) Inflammation/Immunology (1) Metabolic Disease (4)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Targets Recommended: FATP

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-141699

FATP1-IN-1 1 Publications Verification	FATP	Metabolic Disease
FATP1-IN-1 (compound 5k) is a fatty acid transport protein 1 *(FATP1)* inhibitor. FATP1-IN-1 is an inhibition of recombinant human or mouse acyl-CoA synthetase activity of FATP1, with the IC₅₀ values of 0.046 μM or 0.60 μM, respectively .

HY-141700

FATP1-IN-2 2 Publications Verification	FATP	Metabolic Disease
FATP1-IN-2 (compound 12a), an arylpiperazine derivative, is an orally active fatty acid transport protein 1 (FATP1) inhibitor (human IC₅₀=0.43 μM, mouse IC₅₀=0.39 μM) .

HY-116788

Lipofermata Maximum Cited Publications 7 Publications Verification	Bacterial	Infection
Lipofermata is a fatty acid transport protein 2 *(FATP2)* inhibitor. Lipofermata shows fatty acid transport inhibition with an IC₅₀ of 4.84 μM in Caco-2 cells. Lipofermata, an analog of spiro-indoline-thadiazole, shows zinc-specific suppression of antibacterial activity. Lipofermata perturbs zinc homeostasis in E. coli K-12 with a MIC of 16 μM .

HY-RS13144

SLC27A1 Human Pre-designed siRNA Set A 1 Publications Verification	Small Interfering RNA (siRNA)	Others
SLC27A1 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC27A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

SLC27A1 Human Pre-designed siRNA Set A SLC27A1 Human Pre-designed siRNA Set A

HY-116003

12,13-DiHOME	Endogenous Metabolite	Metabolic Disease
12,13-DiHOME is a stimulator of Brown adipose tissue (BAT), as well as a thermogenic lipokine that activates BAT in response to cold. (±)12,13-DiHOME activates BAT fuel uptake and enhances cold tolerance, via promoting the translocation of the FA transporters FATP1 and CD36 to the cell membrane. (±)12,13-DiHOME can be used for research of metabolic disorders .

HY-100671

L002	Histone Acetyltransferase STAT	Cardiovascular Disease Inflammation/Immunology Cancer
L002 is a potent, cell permeable, reversible and specific acetyltransferase p300 (KAT3B) inhibitor with an IC₅₀ of 1.98 μM . L002 binds the acetyl-CoA pocket and competitively inhibits the FATp300 catalytic domain, blocks histone acetylation and p53 acetylation, and inhibits STAT3 activation . L002 has the potential for hypertension-induced cardiac hypertrophy and fibrogenesis treatment .

HY-162028

GaMF1.39	Bacterial	Infection
GaMF1.39 is an antimycobacterial compound, targeting the F-ATP synthase subunit γ. GaMF1.39 displays enhanced anti-tuberculosis activity in combination with ETC inhibitors .

HY-RS27156

Slc27a1 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Slc27a1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Slc27a1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Slc27a1 Rat Pre-designed siRNA Set A Slc27a1 Rat Pre-designed siRNA Set A

HY-RS16240

Slc27a1 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Slc27a1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Slc27a1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Slc27a1 Mouse Pre-designed siRNA Set A Slc27a1 Mouse Pre-designed siRNA Set A

HY-162804

ATP synthase inhibitor 3	Bacterial ATP Synthase	Infection
ATP synthase inhibitor 3 (compound PT6) is an orally active inhibitor of *mycobacterial F-ATP* synthase (IC₅₀*=0.788 μM). ATP synthase inhibitor 3 inhibits the growth of Mycobacterium tuberculosis* H37Rv strain (ATCC-27294) in vitro and depletes intracellular ATP levels at an IC₅₀ value of 30μM .

HY-N0401A

(Z)-Ligustilide 4 Publications Verification	Bacterial Estrogen Receptor/ERR FATP	Infection Metabolic Disease
(Z)-Ligustilide is extracted from Ligusticum chuanxiong Hort, has antimicrobial and antifungal activity, exhibits an average antifungal score of 5.6 . (Z)-Ligustilide is orally active, it inhibits the expression of FATP5 and DGAT, inhibits fatty acid uptake and esterification in mice and has potential as therapeutics for nonalcoholic fatty liver disease (NAFLD) . (Z)-Ligustilide is also able to reactivate ERα, has epigenetic regulation, and is used in the study of tamoxifen-resistant breast cancer .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-116003

12,13-DiHOME	Classification of Application Fields Ketones, Aldehydes, Acids Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite
12,13-DiHOME is a stimulator of Brown adipose tissue (BAT), as well as a thermogenic lipokine that activates BAT in response to cold. (±)12,13-DiHOME activates BAT fuel uptake and enhances cold tolerance, via promoting the translocation of the FA transporters FATP1 and CD36 to the cell membrane. (±)12,13-DiHOME can be used for research of metabolic disorders .

HY-N0401A

(Z)-Ligustilide 4 Publications Verification	Natural Products Classification of Application Fields Source classification Metabolic Disease Dicerothamnus rhinocerotis Umbelliferae Plants Disease Research Fields	Bacterial Estrogen Receptor/ERR FATP
(Z)-Ligustilide is extracted from Ligusticum chuanxiong Hort, has antimicrobial and antifungal activity, exhibits an average antifungal score of 5.6 . (Z)-Ligustilide is orally active, it inhibits the expression of FATP5 and DGAT, inhibits fatty acid uptake and esterification in mice and has potential as therapeutics for nonalcoholic fatty liver disease (NAFLD) . (Z)-Ligustilide is also able to reactivate ERα, has epigenetic regulation, and is used in the study of tamoxifen-resistant breast cancer .

Cat. No.	Compare	Product Name	Species	Source

HY-P77206

	*SLC27A4/FATP4 Protein, Human (HEK293, His)* Long-chain fatty acid transport protein 4; Arachidonate--CoA ligase; ACSVL4	Human	HEK293
	The SLC27A4/FATP4 protein centrally regulates cellular processes by regulating the levels of long-chain fatty acids (LCFA), which are critical for their transport across membranes. As the major LCFA transporter in small intestinal enterocytes, it plays a key role in early embryonic fat absorption. SLC27A4/FATP4 Protein, Human (HEK293, His) is the recombinant human-derived SLC27A4/FATP4 protein, expressed by HEK293 , with N-His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P84889

	SLC27A5 Antibody (YA4586) BAL; ACSB; BACS; FATP5; ACSVL6; FACVL3; FATP-5; VLACSR; VLCSH2; VLCS-H2	IHC-P, ELISA	Human, Mouse
	SLC27A5 Antibody (YA4586) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to SLC27A5.

HY-P82243

	SLC27A4 Antibody (YA1988) SLC27A4; ACSVL4; FATP4; Long-chain fatty acid transport protein 4; FATP-4; Fatty acid transport protein 4; Solute carrier family 27 member 4	WB, ICC/IF, IP	Human
	SLC27A4 Antibody (YA1988) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to SLC27A4.

HY-P83821

	SLC27A2 Antibody (YA3518) VLCS; FATP2; VLACS; ACSVL1; FACVL1; hFACVL1; HsT17226	IHC-P, ELISA	Human
	SLC27A2 Antibody (YA3518) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to SLC27A2.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-RS13144

SLC27A1 Human Pre-designed siRNA Set A 1 Publications Verification		siRNAs Human Pre-designed siRNA Sets
SLC27A1 Human Pre-designed siRNA Set A contains three designed siRNAs for SLC27A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS27156

Slc27a1 Rat Pre-designed siRNA Set A		siRNAs Rat Pre-designed siRNA Sets
Slc27a1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Slc27a1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS16240

Slc27a1 Mouse Pre-designed siRNA Set A		siRNAs Mouse Pre-designed siRNA Sets
Slc27a1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Slc27a1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Natural
Products

Recombinant Proteins

Antibodies

Oligonucleotides